LAMEA Oncology/Anti-cancer drugs Market is Expected to Reach $17,072.2 Million by 2021

LAMEA Oncology/Anti-cancer drugs Market is Expected to Reach $17,072.2 Million by 2021
Press Release

LAMEA Oncology/Anti-Cancer Drugs Market report, published by Allied Market Research, forecasts that the market is expected to garner $17,072.2 million by 2021, registering a CAGR of 8.6% during the period 2015 – 2021. Chemotherapy segment is expected to maintain a dominant share in the LAMEA oncology/cancer drugs market during the forecast period.

High prevalence and rising incidence rates of major types of cancers (such as breast cancer and prostate cancer), emerging treatment algorithms and widespread use of anti-cancer drugs for treating conditions such as blood cancer (leukemia) is expected to drive this market. In addition, growing popularity of biological and targeted drug therapies, which help in improving the patientssurvival time, are projected to provide opportunities in the LAMEA oncology/anti-cancer drugs market. However, factors such as high cost associated with cancer drugs and related side effects are likely to affect the market growth.

Download PDF Report Sample @https://www.alliedmarketresearch.com/request-sample/863

Key findings of LAMEA Oncology/Anti-Cancer Drugs Market:

  • Immunotherapy (biologic therapy) is projected to be the fastest growing segment, registering a CAGR of 12.2% during the forecast period.
  • Chemotherapy is expected to dominate the LAMEA oncology/cancer drugs market throughout the forecast period.
  • Blood cancer segment would lead the LAMEA oncology/cancer drugs market through 2021.
  • Algeria is anticipated to be the fastest growing country in the LAMEA oncology/anti-cancer drugs market, registering a CAGR of 12.8% between 2015 and 2021.
  • Brazil was the highest revenue generating country in the LAMEA oncology/anti-cancer drugs market with about one third of market share in 2015.

Saudi Arabia, is the leading country market from the Middle East region and would continue to lead until 2020, owing to rising incidence rates of cancer, high healthcare expenditure and gross national income (GNI) in Saudi Arabia. Algeria, is expected to witness highest growth rate because of considerable funding, urbanized healthcare facilities and establishment of national healthcare systems. Furthermore, acquisition is the key growth strategy adopted by the leading players in the market, which helped companies to expand their oncology drugs business. In addition, the market players have also adopted strategies, such as approval and collaborations, to sustain the competition in the market. The key companies profiled in the report include, Amgen Inc., AstraZeneca Plc., Roche Diagnostics, GlaxoSmithKline PLC, Merck & Co., Novartis AG, AbbVie Inc. Sanofi, EIMC United Pharmaceuticals (EUP) and Actavis plc.

Make an Enquiry before Buyinghttps://www.alliedmarketresearch.com/purchase-enquiry/863

About Us:

 Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small- & medium-scale enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one-stop solution right from data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients understand the significance and impact of market dynamics. The company applies client’s insight on the factors such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligence support to help clients transform into a prominent business firm.

Contact:

David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

USA/Canada (Toll Free):

+1-800-792-5285, +1-503-894-6022, +1-503-446-1141

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

[email protected]

Web: https://www.alliedmarketresearch.com

Market Pulse: https://blog.alliedmarketresearch.com/

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

This post was originally published on Pharmaceutical Industry